| G2112 | Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months |
| G8682 | Lvf testing documented as being performed prior to discharge or in the previous 12 months |
| G0537 | Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months |
| G9916 | Functional status performed once in the last 12 months |
| G8683 | Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason |
| G9378 | Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) |
| G9376 | Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery |
| G9396 | Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days) |
| G9248 | Patient did not have a medical visit in the last 6 months |
| G9249 | Patient had a medical visit in the last 6 months |
| G9379 | Patient did not achieve flat retinas six months post surgery |
| M1385 | Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up |
| G9377 | Patient did not have the retina attached after 6 months following only one surgery |
| G2173 | Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease) |
| G2175 | Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease) |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
| G9222 | Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3 |
| G9541 | Filter removed within 3 months of placement |
